Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04213079 · ClinicalTrials.gov registry record · NA
Treatments of Mal de Debarquement Syndrome (MdDS) by Habituation of Velocity Storage
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT04213079 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 47 participants.
The verdict
NCT04213079, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
Mal de Debarquement Syndrome (MdDS) is an under-recognized but nevertheless common balance disorder, which in most cases occurs after exposure to prolonged passive motion. The current treatment approaches focus on reducing symptoms, but they can be retriggered. This project aims to shift the focus of MdDS treatment to permanently eliminating the symptom trigger while also minimizing symptoms.
Interventions
- DEVICE re-adaptation of the vestibulo-ocular reflex
- DEVICE Habituation of velocity storage of the vestibulo-ocular reflex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04213079
The ClinicalTrials.gov registry entry for NCT04213079 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which re-adaptation of the vestibulo-ocular reflex is the first listed.
NCT04213079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04213079 about?
NCT04213079 is a clinical study titled "Treatments of Mal de Debarquement Syndrome (MdDS) by Habituation of Velocity Storage". Mal de Debarquement Syndrome (MdDS) is an under-recognized but nevertheless common balance disorder, which in most cases occurs after exposure to prolonged passive motion. The current treatment approaches focus on reducing symptoms, but they can be retriggered. This project aims to shift the focus o...
What is the current status of trial NCT04213079?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2020-06-15. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT04213079?
The interventions under investigation include: re-adaptation of the vestibulo-ocular reflex (DEVICE), Habituation of velocity storage of the vestibulo-ocular reflex (DEVICE).
Who is sponsoring clinical trial NCT04213079?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.